Sanford C. Bernstein reiterated its “Market Perform” rating on ARM Holdings, down 10.2%, while BNP Paribas maintained its “Outperform” recommendation on the stock with a target price of 1300p.
BNP Paribas reiterated its “Neutral” rating on Johnson Matthey, down 0.9%, with a target price of 3300p. JPMorgan Chase maintained its “Overweight” recommendation on the stock with a target price of 3800p.
CSR, up 1.4%, announced that the Japan Fair Trade Commission has approved its acquisition by Qualcomm Global Trading Pte. Ltd., an indirect wholly owned subsidiary of Qualcomm Inc.
In its trading update, LPA Group, up 15.7%, announced that it has won a contract worth around £5.0m to supply equipment for use in London’s Crossrail railway. The company also announced that it has finalised terms of the Framework Agreement with Hitachi to supply electro-mechanical equipment and LED-based lighting for the Intercity Express Programme. In its results for the year ended 31 December 2014,
Quixant, up 4.4%, announced that its revenue rose to $31.9m from $24.2m reported last year, while its operating profit climbed to $7.1m, from $6.0m in 2013. Numis Securities reiterated its “Buy” rating on the stock with a target price of 190p.
Cyan Holdings, up 4.3%, announced that it has signed a non-exclusive distribution agreement with XLink Communications (Pty) Ltd to distribute Cyan’s smart metering and lighting solutions as well as related Internet of Things applications in South Africa.
Gaming Realms, up 3.5%, indicated that it generated revenue of £11.2m for the 15 months ended 31 December 2014, compared to £0.9m in 2013, while it posted an adjusted EBITDA loss of £8.2m for the period compared to a loss of £2.3m. Additionally, the company has reported early success of a proprietary platform which was introduced by Bear Group Limited, the subsidiary of Gaming Realms, in September 2014.
Brady, up 3.3%, announced that it has made an application for 62,950 new ordinary shares of 1.0p each to be admitted to trading on AIM. It is expected that admission will take place on 30 March 2015.
FinnCap raised its rating on Xaar, up 3.1%, to “Buy” from “Hold” with a target price of 500p. Canaccord Genuity initiated coverage on Amino Technologies, up 0.4%, with a “Buy” rating and a target price of 270p.
Horizon Discovery Group, down 5.0%, announced that a group led by the Centre for Process Innovation on behalf of UCB Celltech and Lonza Biologics and including Horizon as a full partner, has been awarded £6.2m as part of the Advanced Manufacturing Supply Chain Initiative. Additionally, the company announced that it has signed an Original Equipment Manufacture deal with ArcherDX Inc. to aid customer validation of its ALK fusion assay kits. N+1 Singer and Panmure Gordon have maintained their “Buy” recommendation on the stock.
UK markets ended mostly in the red last week, amid renewed geopolitical turmoil in the Middle East. The FTSE 100 index declined 2.4% to 6,855.0, while the FTSE AIM 100 Index added 0.1% to finish at 3,210.2. Also, the FTSE techMARK 100 Index retreated 3.1% to finish at 3,781.7.
US markets closed in negative territory in the previous week, as geopolitical fears in the Middle East resurfaced. Also, uncertainty related to the stance of the Federal Reserve on interest rates led to volatility. The DJIA index declined 2.3% to 17,712.7, while the NASDAQ Index dropped 2.7% to 4,891.2.
View the report in full
_________________________________